Prof. Wei Tao is the Farokhzad Family Distinguished Chair for Innovation (Endowed Chair) and Principal Investigator in the Center for Nanomedicine, Co-Director of Nano Immune-Imaging Core, and Faculty Member in the Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women’s Hospital (BWH), Harvard Medical School (HMS). He is also the first Distinguished Chair professor as an assistant professor in the history of his institution. He has published over 160 peer-reviewed, high-impact papers in prestigious journals such as Nature Medicine, Nature Nanotechnology, Science Translational Medicine, Nature Biomedical Engineering, Nature Reviews Materials, Nature Reviews Cancer, Nature Reviews Cardiology, Nature Reviews Methods Primers, PNAS, Nature Protocols, Nature Communications, Science Advances, Chemical Reviews, Chemical Society Reviews, Accounts of Chemical Research, Journal of the American Chemical Society, Angewandte Chemie, Advanced Materials, Materials Today, Matter (Cell Press), Med (Cell Press), etc. He has received multiple awards/grants including the American Heart Association (AHA) Transformational Project Award, American Lung Association (ALA) Courtney Cox Cole Lung Cancer Research Award, AHA Collaborative Sciences Award, ALA Cancer Discovery Award, LEO Foundation Research Grant, Novo Nordisk ValidatioNN Award, American Society of Transplantation (AST) Career Transition Grant (Translational Science), Harvard Catalyst - Cores Facility Program, Harvard/Brigham Health Technology Innovator Award, Distinguished Chair Professorship Foundation, Anaesthesia Department Basic Scientist Grant, Khoury Innovation Award, Center for Nanomedicine Research Fund, Nanotechnology Foundation, Stepping Strong Breakthrough Innovator Award, AHA's Second Century Early Faculty Independence Award, U.S. METAvivor Early Career Investigator Award, MIT Technology Review Top Chinese Innovators Under 35 (2020 TR35), World's Top 2% Scientist (continuously selected since 2019), Chemical Society Reviews (IF~40) Emerging Investigator Award, Advanced Materials (IF~27) Rising Star, Materials Today (IF~21) Rising Star Award, Angewandte Chemie (IF~16) Most Outstanding Referees Award, Materials Horizons (IF~12) Top 10 Outstanding Reviewers Award, etc. He is an elected Fellow of the International Association of Advanced Materials (FIAAM).
He serves on the scientific committee as either an invited award nominator or an invited grant reviewer for European Research Council, NIH (US), DoD (US), Deutsche Forschungsgemeinschaft (German Research Foundation), Swiss National Science Foundation (Switzerland), Dutch Research Council (Netherlands), Israel Science Foundation (Israel), Canadian Institutes of Health Research (Canada), The Xplorer Prize (China), JDRF (Type 1 Diabetes Grand Challenge, UK), VinFuture Prize (VinFuture Foundation, Vietnam), MIT Technology Review Innovators Under 35 (TR35), etc. He also serves on numerous editorial boards including as Founding Editor-in-Chief of Biomedical Technology (Elsevier, KeAi's new journal), Deputy Editor of Exploration (Wiley's new journal), Associate Editor of Journal of Nanobiotechnology (IF~11; Springer Nature & BMC) and Aggregate (IF~14; Wiley); Editor of PNAS (IF~9); Guest Editor of eLife, etc.; Senior Editorial Board Member of Materials Today (IF~21, Elsevier), Bioactive Materials (IF~18; Elsevier, KeAi), Nano-Micro Letters (IF~32; Springer Nature), etc.; and Advisory Board Member of Matter (IF~17; Cell Press).
See Prof. Tao's interview (together with Prof. Robert Langer/MIT, Prof. Samir Mitragotri/Harvard, Dr. Nicholas Warne/Pfizer, Dr. Steffen Panzner/BioNTech, etc.) in Nature Medicine (https://www.nature.com/articles/s41591-022-01826-y).
List of Research Areas:
Biomaterials, RNA Medicine, Drug Delivery, Biomedical Engineering, Nanomedicine.